ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
3364	National Human Genome Research Institute	Html	null	FAQ About Newborn Screening	Newborn screening tests use a dried blood sample collected during the first week after birth to measure the presence of disease biomarkers (a measurable substance or characteristic that is indicative of a disease).			CLICK HERE
15538	National Institute of Allergy and Infectious Diseases	Html	en	NIAID's Programs on Asthma in the Inner City	Recognizing that asthma severity in inner-city children is disproportionately high, NIAID has sponsored research to reduce the public health burden that asthma presents in inner-city populations. Beginning in 1991, NIAID has supported three consecutive inner-city asthma research programs, which have been successful in reducing asthma severity in children.	inner-city populations 0.579525 Morgan WJ 0.496915 cockroach allergen 0.471241 inner-city children. 0.516784 asthma severity 0.746089 inner-city adolescents 0.569622 environmental intervention study 0.506189 clinical trials 0.457073 Infectious Diseases networks 0.482159 asthma exacerbations 0.604543 asthma attacks 0.618501 Gergen PJ 0.506952 City Anti-IgE Therapy 0.499916 asthma 0.9777 Pongracic JA 0.498 Szefler SJ 0.504609 Busse WW. Management 0.518055 Asthma Control Evaluation 0.678562 asthma treatment guidelines 0.681693 Gruchalla RS 0.496061 Allergy Clin Immunol. 0.483813 Busse WW. 0.518705 asthma management 0.634222 omalizumab 0.464849 severe allergic asthma 0.661933	asthma morbidity 0.639521 ICAC investigators 0.510592 CA. Randomized trial 0.488723 guidelines-based asthma therapy 0.667931 asthma presents 0.660928 nitric oxide level 0.504737 William Busse 0.501488 follow-on clinical trial 0.490114 asthma treatment 0.724256 public health burden 0.502806 exhaled nitric oxide 0.589522 at-risk children 0.467554 inner city 0.546793 Liu AH 0.496615 Teach SJ 0.501285 clinical guidelines 0.486081 principal investigators 0.485986 Asthma counselors 0.64051 ICAC program 0.497263 inner-city asthma research 0.793594 basic research sites 0.543997 year-long study 0.459719 inner-city children 0.771731 asthma symptoms 0.641572	CLICK HERE
15540	National Institute of Allergy and Infectious Diseases	Html	en	NIAID Paylines -- NIAID Research Funding	Fiscal year paylines for all award types.	Final NIAID Paylines 0.905895 POs contact information 0.229921 interim paylines 0.666704 success rates 0.214968 Email Alerts 0.25735 NIAID funds 0.432012	Research Project Success 0.236611 program officer 0.217587 overall impact/priority score 0.255863 initial paylines 0.594349 Research Portfolio Online 0.237047	CLICK HERE
15541	National Institute of Allergy and Infectious Diseases	Html	en	Sample Applications and Summary Statements -- NIAID Research Funding	Sample Applications and Summary Statements and a list of all samples and examples that are part of the grant application from NIAID and NIH -- NIAID Research Funding	application format 0.907608 grantee organization 0.765229 funding opportunity 0.767168 Dr. Andrew Hemmert 0.871038 new research projects 0.933476 feasibility studies 0.741985 R33 phase 0.759832 ethnic groups 0.738984 sound examples 0.760636 sample applications 0.791811 widely anticipated resource 0.905833 research community 0.804124 major recipients 0.749258 independent research career 0.905416 small-scale research projects 0.918897 predoctoral students 0.755344 good grantsmanship 0.776715 limited resources 0.753355 Research Enhancement Award 0.912673 grant renewal 0.750527 model systems 0.747297 R21 phase 0.802738 original grant application. 0.876558 exceptional applications 0.795607	two-phased award 0.744601 latest application format 0.89336 summary statements 0.774822 possible transition 0.745699 new samples 0.775894 milestone-driven exploratory 0.747537 new investigators 0.919996 domestic small businesses 0.862103 research training 0.778846 NIH example forms 0.929049 Dr. Hemmert 0.748615 nonprofit educational purposes 0.880734 short period 0.753535 Small Business Programs 0.860069 R21 funds novel 0.915071 research environment 0.789167 NIH support 0.763875 disadvantaged backgrounds 0.737728 *Dr. Mark Poritz 0.868098 biomedical research 0.780582 Dr. Poritz 0.748763 educational institutions 0.749988 program supports 0.759468 scientific ideas 0.747402	CLICK HERE
15545	National Institute of Allergy and Infectious Diseases	Html	en	Methicillin-Resistant Staphylococcus aureus MRSA, Antimicrobial Resistance	NIAID conducts and supports research on methicillin-resistant Staphylococcus aureus, MRSA--drug-, or antimicrobial-, resistant bacteria that has become a serious public health concern.	Allergy 0.341577 Require 0.335974 Experts 0.328592 Research > Antimicrobial 0.486656 Pathway 0.34693 methicillin-resistant staphylococcus aureus 0.971182 controllable nuisance 0.508668 HIV Vaccine 0.518468 NIAID-Supported Institutions 0.464562 Research > NIAID 0.500955 MRSA 0.488992 News 0.326356 new strains 0.473848	Universal Influenza Vaccine 0.682447 HIV/AIDS Pandemic Likely 0.665604 public health concern 0.611156 National Institute 0.496139 NIH 0.350088 allergic diseases 0.501528 severe infections 0.473944 Role 0.327169 Infectious Diseases 0.524019 decades 0.338877 hospital-acquired infection 0.507902 Durable End 0.489538	CLICK HERE
15548	National Institute of Allergy and Infectious Diseases	Html	en	Tuberculosis TB, NIAID, NIH	NIAID is examining TB at its fundamental levels through research to develop faster diagnosis, better vaccines, and shorter treatment times.	animal models 0.484339 treatment strategies 0.479645 new TB drug 0.750789 drug-resistant strains 0.584127 multidrug-resistant TB 0.705257 optimal drug combinations 0.547291 TB disease 0.789313 research findings 0.480296 severe airborne disease 0.575915 research 0.505253 new candidate drugs 0.571748 death worldwide 0.485014 novel TB drugs 0.766874 national history 0.484991 candidate drugs 0.572469 active TB disease 0.746928 TB deaths 0.714042 major causes 0.487119 MedlinePlus tuberculosis site 0.583865 genetic drug 0.486206 comprehensive portfolio 0.485226 TB bacterium 0.688383 latent infections 0.478461 middle-income countries 0.49248	risk factors 0.478783 World Health Organization 0.559465 research infrastructure 0.479568 early TB disease 0.745692 NIAID 0.606471 diagnostic potential 0.480354 people 0.530993 TB 0.982786 biomedical research 0.486422 new TB drugs 0.754513 HIV deaths 0.484548 Mycobacterium tuberculosis 0.614224 private industry 0.478347 public health practices 0.540649 TB diagnosis 0.691172 clinical studies 0.55766 prevention strategies 0.478336 NIAID priority 0.54559 vaccine clinical trials 0.538763 Mtb 0.530457 drug resistance 0.554266 causative agent 0.484545 basic research 0.485797	CLICK HERE
15552	National Institute of Allergy and Infectious Diseases	Html	en	Dengue Fever, NIAID, NIH	NIAID health and research information on dengue fever	dengue animal models 0.637025 related dengue viruses 0.700576 New research findings 0.39085 point-of-care machine 0.349211 dengue infection 0.729539 economic burden 0.353666 dengue vaccines 0.665616 muscle pain 0.354058 rapid dengue diagnosis 0.618858 small molecule drugs 0.38263 Western hemisphere 0.353064 clinical trials 0.351867 live-attenuated dengue viruses 0.642326 dengue-endemic countries 0.348281 dengue research projects 0.662649 diagnostic tests 0.396946 specific diagnostic tests 0.387357 human trials 0.348533 community-based prevention programs 0.394083 vaccine approach 0.349325 recombinant version 0.351126 viral factors 0.354135 dengue fever 0.846342 laboratory-based international surveillance 0.396575 rapid diagnostic tests 0.391709	healthcare providers 0.353653 treatment strategies 0.350986 United States 0.35404 global health threat 0.393267 dengue shock syndrome 0.744003 NIAID researchers 0.395179 infected people 0.351147 different viral dengue 0.634725 public health 0.35259 NIAID research priorities 0.443797 dengue disease 0.600916 recombinant proteins 0.349944 Health experts 0.357315 severe forms 0.399676 dengue 0.999102 viral proteins 0.352028 MedlinePlus dengue site 0.654335 viral vectors 0.355429 basic research activities 0.394177 dengue hemorrhagic fever 0.763697 NIAID projects 0.394476 new treatment options 0.386411 effective vaccine 0.349229 infectious disease 0.367495	CLICK HERE
15553	National Institute of Allergy and Infectious Diseases	Html	en	Autoimmune Lymphoproliferative Syndrome (ALPS)	General and NIAID research information about Autoimmune lymphoproliferative syndrome (ALPS).	red blood cells 0.498965 Genetics Home Reference 0.386541 common type 0.27372 enlarged spleen 0.273296 treatment strategies 0.256376 clinical findings 0.247554 better understanding 0.262253 inflammatory bowel diseases 0.386467 primary immune deficiency 0.43025 normal cell lifecycle 0.380592 genetic defects 0.264434 low blood cell 0.387723 abnormal buildup 0.395762 low count 0.525489 common autoimmune diseases 0.498412 blood cells. 0.260493 research questions 0.258643 autoimmune lymphoproliferative syndrome 0.860748 systemic lupus erythematosus 0.388262 NIAID researchers 0.384049 white blood cells 0.708626 numerous autoimmune problems 0.563557 lymphoproliferative syndrome site 0.41581 related disorders 0.38884	major clinical symptoms 0.374436 NIAID PIDD site 0.506663 current management 0.256481 National Library 0.256237 increased risk 0.262725 PIDD research 0.257719 autoimmune diseases 0.588163 effective treatments 0.265251 risk factors 0.248383 white blood cell 0.447537 cell death 0.256903 genetic characteristics 0.264791 patient care 0.257891 rheumatoid arthritis 0.249292 rare genetic disorder 0.433441 ALPS 0.995498 NIAID focus 0.38608 FAS gene cause 0.410071 autoimmune destruction 0.357642 lymph nodes 0.291536 FAS gene 0.591557 genome sequencing 0.254615 debilitating symptoms 0.274164	CLICK HERE
15804	National Institute of Allergy and Infectious Diseases	Html	en	Food Allergy	NIAID supports food allergy research, which spans the spectrum from basic research in allergy and immunology to clinical trials that are testing new strategies to treat and prevent food allergy.	prevention options 0.339349 ongoing clinical trials 0.370651 lead Institute 0.347558 NIAID-funded scientists 0.33777 new strategies 0.345355 current evidence-based recommendations 0.370416 policy report 0.342135 immune responses 0.337553 children 0.321267 faster rate 0.335898 observational studies 0.345615 significant progress 0.335698 practical ways 0.34177 National Institutes 0.383015 risk factors 0.342668 Personal medical history 0.374798 NIAID-supported study 0.337131 important role 0.337607 eosinophilic esophagitis 0.3439 United States 0.385897 allergic conditions 0.339157 common allergens plays 0.380868 gut bacteria 0.371845 Drug Administration 0.341666 scientific community 0.339254	food allergies 0.381405 NIAID researchers 0.401866 allergy clinical trials 0.47886 life-threatening response 0.347529 basic studies 0.337145 early introduction 0.341065 experimental immunotherapies 0.343557 new treatments 0.33937 careful monitoring 0.340519 active clinical trials 0.373969 baked milk 0.396405 NIAID-funded study 0.336779 comprehensive food allergy 0.510173 NIAID 0.483382 food allergy 0.951641 milk allergy foods 0.4779 biomedical research 0.341796 Clinical Immunology 0.339341 National Academies 0.341431 food allergy research 0.643116 family history 0.340464 oral allergy syndrome 0.484032 food allergens 0.388332 expert panel 0.337968	CLICK HERE
15981	National Institute of Allergy and Infectious Diseases	Video	en	Influenza: Get the (Antigenic) Drift	Have you ever wondered why you need a flu vaccination each year? The National Institute of Allergy and Infectious Diseases explains the ever-changing nature of influenza viruses.	Action MOA Animation 0.579913 Shomu 0.416725 Allergy 0.416577 SwineFlu 0.416001 Daniel Levy 0.496516 flutube100 0.416238 Osmosis 0.416074 H1N1 Swine Flu 0.627108 Unpredictable Threat 0.498722 flu vaccination 0.597572 milos velja 0.493184 World Health Organization 0.57148 1918 Flu Pandemic 0.627835 flu virus mechanism 0.693678 reverse transcriptase 0.494547 Duration 0.949875 Virus Invades 0.512664 AMAZING DOCUMENTARY 0.485888 autoplay 0.453443 HIV life cycle 0.567135 Carolyn Bertozzi 0.598025 Infectious Diseases 0.507143 Influenza H1N1 Mechanism 0.7022 VIRUS EVOLUTION 0.501245 antigenic shift 0.607123	influenza 0.762967 720p 0.423131 iBioEducation 0.42898 Influenza animation 0.642901 Influenza Pandemics Occur 0.718554 Biology 0.416713 video 0.418444 Genetic Shift 0.503494 Berkeley/HHMI 0.429072 ever-changing nature 0.51424 views 0.737316 National Institute 0.509002 Fighting flu 0.555906 Influenza infection model 0.670194 Immune Response 0.487687 David Hager 0.509045 Scientific Animations 0.498803 DOCUMENTARY TUBE 0.482643 NIAID 0.456714 Influenza Virus Infection 0.688245 Flu Attack 0.564409 influenza viruses 0.646604 Nucleus Medical Media 0.585917 Million People 0.484786	CLICK HERE